These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8903663)

  • 1. Chronic alpha-1-adrenergic blockade increases sympathoneural but not adrenomedullary activity in patients with essential hypertension.
    Jacobs MC; Lenders JW; Willemsen JJ; Thien T
    J Hypertens; 1995 Dec; 13(12 Pt 2):1837-41. PubMed ID: 8903663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of low- and high-intensity lower body negative pressure on noradrenaline and adrenaline kinetics in humans.
    Jacobs MC; Goldstein DS; Willemsen JJ; Smits P; Thien T; Lenders JW
    Clin Sci (Lond); 1996 May; 90(5):337-43. PubMed ID: 8665770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
    Chang PC; Kriek E; van Brummelen P
    J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of doxazosin and atenolol on smoking-induced peripheral vasoconstriction in hypertensive habitual smokers.
    Lecerof H; Bornmyr S; Lilja B; De Pedis G; Hulthén UL
    J Hypertens Suppl; 1990 Sep; 8(5):S29-33. PubMed ID: 1981074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients.
    Mores N; Martire M; Pistritto G; Volpe AR; Menini E; Folli G; Cardillo C
    J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G; Hasegawa K; Kuji T; Ogawa N; Shimura G; Umemura S; Tochikubo O
    Diabet Med; 2005 Oct; 22(10):1394-400. PubMed ID: 16176202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of exogenous adrenaline and noradrenaline on vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man.
    Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
    J Hypertens Suppl; 1984 Dec; 2(3):S119-21. PubMed ID: 6100733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
    Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
    Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N
    Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term beta 1-adrenergic blockade restores adrenomedullary activity in primary hypertension.
    Jacobs MC; Lenders JW; Smits P; Willemsen JJ; Tack C; Thien T
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):338-42. PubMed ID: 9300318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
    Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interactions between alpha 1, alpha 2 and beta receptors in the blood pressure effects of adrenaline and noradrenaline in the dog].
    Mouillé P; Dabiré H; Joly G; Schmitt H
    J Pharmacol; 1983; 14(3):325-32. PubMed ID: 6138461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma adrenaline and noradrenaline in essential and renal hypertension (author's transl)].
    Skrabal F; Auböck J; Hörtnagl H; von Brücke T
    Wien Klin Wochenschr; 1981 May; 93(10):321-5. PubMed ID: 7020260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
    Christensen M; Ibsen H; Worck R
    Clin Sci (Lond); 2005 Feb; 108(2):113-9. PubMed ID: 15383007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.